Background and Purpose: Huntington's disease (HD) is a dominantly inherited neurodegenerative disorder with varied prevalence in different populations, which may be associated with specific haplotypes. This study aimed to explore the haplotypes encompassing the HTT gene in the Chinese population.References:
Methods: A total of 406 individuals with HD and 59 normal relatives from 253 families with HD were enrolled. A total of 29 tag single nucleotide polymorphisms (tSNPs) were selected and genotyped for the haplotype analysis.
Results: In stage one, we used 18 tSNPs to replicate the distribution of three major haplogroups (A, B, C). We found that risk-associated haplogroup variants A1 and A2, enriched on Caucasian HD chromosomes, were totally absent from both Chinese HD and control chromosomes, and the distributions of haplogroups between HD and control chromosomes were similar. Therefore, in stage two, we used 29 tSNPs (including the18 tSNPs) to define new haplogroups (I, II, III) and found that haplogroup I accounted for 61.4% on HD chromosomes and 34.4% on control chromosomes, indicating that haplogroup I was enriched on Chinese HD chromosomes.
Conclusions: This is the first haplotype analysis encompassing HTT in the Chinese population. The results contribute to explaining the low prevalence of HD in China and provide a better understanding of genetic diversity in the HTT region.
(© 2019 European Academy of Neurology.)
Kremer B, Goldberg P, Andrew SE, et al. A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats. N Engl J Med 1994; 330: 1401-1406.
Walker FO. Huntington's disease. Lancet 2007; 369: 218-228.
Conneally PM. Huntington disease: genetics and epidemiology. Am J Hum Genet 1984; 36: 506-526.
Nakashima K, Watanabe Y, Kusumi M, et al. Epidemiological and genetic studies of Huntington's disease in the San-in area of Japan. Neuroepidemiology 1996; 15: 126-131.
Chang CM, Yu YL, Fong KY, et al. Huntington's disease in Hong Kong Chinese: epidemiology and clinical picture. Clin Exp Neurol 1994; 31: 43-51.
Spinney L. Uncovering the true prevalence of Huntington's disease. Lancet Neurol 2010; 9: 760-761.
Chen YY, Lai CH. Nationwide population-based epidemiologic study of Huntington's disease in Taiwan. Neuroepidemiology 2010; 35: 250-254.
Warby SC, Montpetit A, Hayden AR, et al. CAG expansion in the Huntington disease gene is associated with a specific and targetable predisposing haplogroup. Am J Hum Genet 2009; 84: 351-366.
Aronin N, DiFiglia M. Huntingtin-lowering strategies in Huntington's disease: antisense oligonucleotides, small RNAs, and gene editing. Mov Disord 2014; 29: 1455-1461.
Kay C, Skotte NH, Southwell AL, Hayden MR. Personalized gene silencing therapeutics for Huntington disease. Clin Genet 2014; 86: 29-36.
Rubinsztein DC, Leggo J, Goodburn S, Barton DE, Ferguson-Smith MA. Haplotype analysis of the delta 2642 and (CAG)n polymorphisms in the Huntington's disease (HD) gene provides an explanation for an apparent ‘founder’ HD haplotype. Hum Mol Genet 1995; 4: 203-206.
Zhang Y, Engelman J, Friedlander RM. Allele-specific silencing of mutant Huntington's disease gene. J Neurochem 2009; 108: 82-90.
Lee JM, Gillis T, Mysore JS, et al. Common SNP-based haplotype analysis of the 4p16.3 Huntington disease gene region. Hum Mol Genet 1994; 3: 93-98.
Novelletto A, Persichetti F, Sabbadini G, et al. Analysis of the trinucleotide repeat expansion in Italian families affected with Huntington disease. Hum Mol Genet 1994; 3: 93-98.
Dong Y, Sun YM, Liu ZJ, Ni W, Shi SS, Wu ZY. Chinese patients with Huntington's disease initially presenting with spinocerebellar ataxia. Clin Genet 2013; 83: 380-383.
Lin X, Lu D, Gao Y, et al. Genome-wide association study identifies novel loci associated with serum level of vitamin b12 in Chinese men. Hum Mol Genet 2012; 21: 2610-2617.
Dong Y, Ni W, Chen WJ, et al. Spectrum and classification of ATP7B variants in a large cohort of Chinese patients with Wilson's disease guides genetic diagnosis. Theranostics 2016; 6: 638-649.
Southwell AL, Skotte NH, Kordasiewicz HB, et al. In vivo evaluation of candidate allele-specific mutant huntingtin gene silencing antisense oligonucleotides. Mol Ther 2014; 22: 2093-2106.
Skotte NH, Southwell AL, Ostergaard ME, et al. Allele-specific suppression of mutant huntingtin using antisense oligonucleotides: providing a therapeutic option for all Huntington disease patients. PLoS ONE 2014; 9: e107434.
van Bilsen PH, Jaspers L, Lombardi MS, Odekerken JC, Burright EN, Kaemmerer WF. Identification and allele-specific silencing of the mutant Huntingtin allele in Huntington's disease patient-derived fibroblasts. Hum Gene Ther 2008; 19: 710-719.
Jiang H, Sun YM, Hao Y, et al. Huntingtin gene CAG repeat numbers in Chinese patients with Huntington's disease and controls. Eur J Neurol 2014; 21: 637-642.
Li HL, Li XY, Dong Y, et al. Clinical and genetic profiles in Chinese patients with Huntington's disease: a ten-year multicenter study in China. Aging Dis 2019; 10: 1003-1011.
Li XY, Zhang YB, Xu M, et al. Effect of apolipoprotein E genotypes on Huntington's disease phenotypes in a Han Chinese population. Neurosci Bull 2019; 35: 756-762.